Диагностика туберкулеза у больных с терминальной стадией хронической болезни почек

DOI: https://doi.org/10.29296/25877305-2020-02-05
Скачать статью в PDF
Номер журнала: 
2
Год издания: 
2020

О. Гордеева, Н. Карпина

В категории лиц с вторичным иммунодефицитом ежегодно растет число больных хронической болезнью почек (ХБП) в терминальной стадии. Заболеваемость и смертность от туберкулеза среди таких больных выше в десятки раз, чем в общей популяции. Диагностика туберкулеза у больных ХБП крайне сложна: манифестация туберкулезного процесса не имеет характерной клинико-рентгенологической картины, этиологическая верификация редко достигает 50%, а возможности иммунодиагностики туберкулеза изучены недостаточно.
Ключевые слова: 
фтизиатрия
нефрология
диагностика туберкулеза
хроническая болезнь почек в терминальной стадии
диализ
трансплантация почки
иммунодиагностика
Для цитирования
О. Гордеева, Н. Карпина Диагностика туберкулеза у больных с терминальной стадией хронической болезни почек . Врач, 2020; (2): 23-29 https://doi.org/10.29296/25877305-2020-02-05

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

Список литературы: 
  1. Тареева Е.И. (ред.) Нефрология. Руководство для врачей. 2-е изд., перераб. и доп. / М.: Медицина, 2000; 687 с. [Tareeva E.I. (red.) Nefrologiya. Rukovodstvo dlya vrachei. 2-e izd., pererab. i dop. / M.: Meditsina, 2000; 687 s. (in Russ.)]
  2. Summary reports of 2016 [Electronic resource]. Global observatory on donation and transplantation activities. Mode of access: http://www.transplant-observatory.org/reports/
  3. Neirynck N., Vanholder R., Schepers E. et al. An update on uremic toxins // Int. Urol. Nephrol. – 2013; 45: 139–50. DOI: 10.1007/s11255- 012-0258-1.
  4. Papakrivopoulou E., Booth J., Pinney J. et al. Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients // Nephron Extra. – 2012; 2 (1): 48–54. DOI: 10.1159/000337338.
  5. Щербань Н.А. Эндобронхиальная микрогемоциркуляция и клинико-морфофункциональная характеристика патологических процессов в бронхолегочной системе у больных хронической болезнью почек (клинико-экспериментальное исследование). Дис. ... д-ра мед. наук. Благовещенск, 2011; 248 с. [Shcherban’ N.A. Endobronkhial’naya mikrogemotsirkulyatsiya i kliniko-morfofunktsional’naya kharakteristika patologicheskikh protsessov v bronkholegochnoi sisteme u bol’nykh khronicheskoi bolezn’yu pochek (kliniko-eksperimental’noe issledovanie). Dis. ... d-ra med. nauk. Blagoveshchensk, 2011; 248 s. (in Russ.)].
  6. Ates G., Yildiz T., Danis R. et al. Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region // Renal failure. – 2010; 32 (1): 91–5. DOI: 10.3109/08860220903367528.
  7. Moore D., Lightstone L., Javid B. et al. High rates of tuberculosis in end-stage renal failure: the impact of international migration // Emerg. Infect. Dis. – 2002; 8 (1): 77–8. DOI: 10.3201/eid0801.010017.
  8. Rao T., Ram R., Swarnalatha G. et al. Tuberculosis in haemodialysis patients: A single centre experience // Indian J. Nephrol. – 2013; 23 (5): 340–5. DOI: 10.4103/0971-4065.116296.
  9. Christopoulos A., Diamantopoulos A., Dimopoulos P. et al. Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial // BMC Nephrology. – 2009; 10 (1): 36. DOI: 10.1186/1471-2369-10-36.
  10. Unsal A., Elbis A., Taner B. et al. Tuberculosis in dialysis patients: a nine-year retrospective analysis // J. Infect. Dev. Ctries. – 2013; 7 (3): 208–13. DOI: 10.3855/jidc.2664.
  11. Chou K., Fang H., Bai K. et al. Tuberculosis in maintenance dialysis patients // Nephron. – 2001; 88 (2): 138–43. DOI: 10.1159/000045974.
  12. Muñoz P., Rodriguez С., Bouza Е. Mycobacterium tuberculosis infection in recipients of solid organ transplants // Clin. Infect. Dis. – 2005; 40 (4): 581–7. DOI: 10.1086/427692.
  13. Агафонова С.Г., Прокопенко Е.И. Туберкулез у больных с терминальной хронической почечной недостаточностью (Обзор литературы) // Нефрология и диализ. – 2004; 6 (2): 108–16 [Agafonova S.G., Prokopenko E.I. Tuberculosis in patients with end-stage renal disease // Nefrologiya i dializ. – 2004; 6 (2): 108–16 (in Russ.)].
  14. Cavusoglu C., Cicek-Saydam C., Karasu Z. et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid organ transplant recipients // Clin. Transplant. – 2002; 16 (4): 257–61. DOI: 10.1034/j.1399-0012.2002.01098.x.
  15. Reis-Santos B., Gomes T., Horta B. et al. Tuberculosis prevalence in renal transplant recipients: systematic review and meta-analysis // Brazil. J. Nephrol. – 2013; 35 (3): 206–13. DOI: 10.5935/0101-2800.20130033.
  16. Canet E. Incidence et prognostic de l`infection a mycobacterium tuberculosis dans le cohort multicentrique de patients transplantesrenaux en France de 1986 a 2006: Diplomed`etat de docteur un medicine / Nantes, 2008; 67 р.
  17. Ватазин А.В., Прокопенко Е.И., Перлин Д.В. и др. Особенности диагностики туберкулеза у больных хронической почечной недостаточностью на программном гемодиализе и после трансплантации почки // Нефрология и диализ. – 1999; 1 (1): 39–44 [Vatazin A.V., Prokopenko E.I., Perlin D.V. et al. Osobennosti diagnostiki tuberkuleza u bol’nykh khronicheskoi pochechnoi nedostatochnost’yu na programmnom gemodialize i posle transplantatsii pochki // Nefrologiya i dializ. – 1999; 1 (1): 39–44 (in Russ.)].
  18. Abdelrahman M., Sinha A., Karkar A. Tuberculosis in end stage renal disease patients on hemodialysis // Hemodialysis Int. – 2006; 10 (4): 360–4. DOI: 10.1111/j.1542-4758.2006.00130.x.
  19. Kayabasi H., Sit D., Kadiroglu A. et al. The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: experience of a dialysis center in southeast Turkey // Renal failure. – 2008; 30 (5): 513–9. DOI: 10.1080/08860220802064721.
  20. Hussein M., Mooij J., Roujouleh H. Tuberculosis and chronic renal disease // Semin. Dial. – 2003; 16 (1): 38–44.
  21. Yang, W., Han F., Zhang X. et al. Extra-pulmonary tuberculosis infection in the dialysis patients with end stage renal diseases: case reports and literature review // Journal of Zhejiang University SCIENCE B. – 2013; 14 (1): 76–82. DOI: 10.1631/jzus.B1200244.
  22. Segall L., Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy // Clin. J. Am. Soc. Nephrol. – 2010; 5 (6): 1114–22. DOI: 10.2215/CJN.09231209.
  23. Higuita L., Nieto-Rios J., Daguer-Gonzalez S. et al. Tuberculosis in renal transplant patients: The experience of a single center in Medellin-Colombia, 2005-2013 // Brazil. J. Nephrol. – 2014; 36 (4): 512–8. DOI: 10.5935/0101-2800.20140073.
  24. Usta A., Shawish T., Mishra A. et al. Living related kidney transplantation in Libya: a single center experience // Transplant. Proc. – 2008; 40: 3428–33. DOI: 10.1016/j.transproceed.2008.06.063.
  25. Jebali H., Barrah S., Rais L. et al. The diagnosis of tuberculosis in dialysis patients// Saudi J. Kidney Dis. Transplant. – 2017; 28 (6): 1362–8. DOI: 10.4103/1319-2442.220882.
  26. Lakadamyali H., Lakadamyali H., Ergun T. Thorax CT findings in symptomatic hemodialysis patients // Transplant. Proc. – 2008; 40 (1): 71–6. DOI: 10.1016/j.transproceed.2007.11.037.
  27. Федеральные клинические рекомендации по организации и проведению микробиологической и молекулярно-генетической диагностики туберкулеза / М., 2014; с. 10–8. [Federal’nye klinicheskie rekomendatsii po organizatsii i provedeniyu mikrobiologicheskoi i molekulyarno-geneticheskoi diagnostiki tuberkuleza / M., 2014; s. 10–8 (in Russ.)].
  28. Kane Y., Faye M., Lemrabott A. Relevance of the GeneXpert Test for the Diagnosis of TB in Chronic Hemodialysis Patients in Casamance, South of Senegal // J. Kidney. – 2016; 2: 133. DOI: 10.4172/2472-1220.1000133.
  29. ATS/CDC Statement Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection // Am. J. Respir. Crit. Care Med. – 2000; 161: 1376–95.
  30. Simon H. Mycobacterial and nocardial infections in the compromised host. Clinical approach to infection in the compromised host. R.H. Rubin, L.S. Young (eds.). 2nd ed. / New York: Plenum, 1988; 221–51.
  31. Poduval R., Hammes M. Tuberculosis screening in dialysis patients – is the tuberculin test effective? // Clin. Nephrol. – 2003; 59 (6): 436–40.
  32. Прил. №4 к Приказу Минздрава России от 21.03.2003 №109 «Инструкция по применению туберкулиновых проб» (в ред. Приказа Минздравсоцразвития РФ от 29.10.2009 №855) [Pril. №4 k Prikazu Minzdrava Rossii ot 21.03.2003 g. №109 «Instruktsiya po primeneniyu tuberkulinovykh prob» (v red. Prikaza Minzdravsotsrazvitiya RF ot 29.10.2009 №855) (in Russ.)].
  33. Slogotskaya. L.V., Litvinov V., Ovsyankina E. et al. Results of QuantiFERON-TB Gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection // Paediatric Resp. Rev. – 2013; 14 (2): S65.
  34. Slogotskaya L.V., Bogorodskaya E., Sentchichina O. et al. Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children // Eur. Resp. J. – 2015; 46 (S59): РА4524.
  35. Shovkun L., Aksenova V., Kudlay D. et al. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA) // Eur. Resp. J. – 2018; 52 (Suppl. 62): PA2733.
  36. Slogotskaya L.V., Litvinov V., Kudlay D.A. et al. New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection // Eur. Resp. J. – 2012; 40 (S56): 416.
  37. Старшинова А.А., Кудлай Д.А., Довгалюк И.Ф. и др. Эффективность применения новых методов иммунодиагностики туберкулезной инфекции в Российской Федерации // Педиатрия. – 2019; 98 (4): 229–35 [Starshinova A.A., Kudlay D.A., Dovgalyuk I.F. et al. Efficacy of new methods of tuberculosis infection immunodiagnostics in the Russian Federation // Pediatria. – 2019; 98 (4): 229–35 (in Russ.)]. DOI: 10.24110/0031-403X-2019-98-4-229-235
  38. Pai M., Riley L., Colford J. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review // Lancet Infect. Dis. – 2004; 4 (12): 761–76. DOI: 10.1016/S1473-3099(04)01206-x.
  39. Mazurek G., Jereb J., Vernon A. et al. Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection // MMWR Recomm. Rep. – 2010; 59 (RR-5): 1–25.
  40. Inoue T., Nakamura T., Katsuma A. et al. The value of QuantiFERON® TB-Gold in the diagnosis of tuberculosis among dialysis patients // Nephrol. Dial. Transplant. – 2009; 24 (7): 2252–7.
  41. Lai C., Tan C., Liao C. et al. Diagnosis of pulmonary tuberculosis among dialysis patients by enzyme-linked immunospot assay for interferon-γ // Nephrol. Dial. Transplant. – 2009; 24 (8): 2605–6. DOI: 10.1093/ndt/gfp224.
  42. Ferguson T., Tangri N., Macdonald K. et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis // Transplantation. – 2015; 99 (5): 1084–91. DOI: 10.1097/TP.0000000000000451.
  43. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management / Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
  44. Canadian Tuberculosis Committee: Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS) // Can. Commun. Dis. Rep. – 2008; 34: 1–13.
  45. National Tuberculosis Advisory Committee: Position statement on interferon-gamma release immunoassays in the detection of latent tuberculosis infection [Electronic resource]. Australian Government, Department of Health and Ageing. – Mode of access: Available at http://www.health.gov.au/internet/m-ain/pub¬lishing.nsf/Content/cdna-ntac-interferon.htm
  46. Japan Society for Tuberculosis: Guideline for the use of Quantiferon TB-2G. Committee of TB Prevention // Kekkaku. – 2013; 88 (1): 33–7.
  47. Health Protection Agency of UK: Position statement on the use of Interferon Gamma Release Assay (IGRA) tests for tuberculosis (TB) [Electronic resource] // Public Health England. – Mode of access: http://www.hpa.org.uk/web/HPA¬webFile/HPAweb_C/1214808549127
  48. Swiss Lung League: Detection of latent tuberculosis using a blood test (interferon-gamma) [Electronic resource] / Berne, Swiss Federal Office of Public Health. – Mode of access: http://www.sgpp-schweiz.ch/downloads_cms/gamma-interferontest_bag_7_11_05.pdf
  49. Position statement on the use of the new immunological tests for the diagnosis of latent tuberculosis infection [Electronic resource] / Infections and Tuberculosis Study Groups of the Italian Hospital Pulmonology Association and the Italian Society of Respiratory Medicine // Aiponet. – Mode of access: http://www.aiponet.it/download/1617.pdf (in Italian).
  50. Committee for Practical Tuberculosis Control: Positioning of interferon gamma release assays in the diagnosis of tuberculosis [Electronic resource] // NVMM. – Mode of access: http://www.nvmm.nl/nvmm/nvmmcms.nsf/uploads/16D33316B-72BA199C12573FB0043D583/$FILE/251.101%20Plaatsbepaling-%20IGRA%20oktober%202007.pdf (in Dutch).
  51. French National Authority for Health: Interferon gamma release assays for the diagnosis of Tuberculosis infection [Electronic resource] // HAS. – Mode of access: http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_detec¬tion_de_linterferon-gamma.pdf (in French).
  52. National TB Advisory Committee: Guidelines on the prevention and control of tuberculosis in Ireland [Electronic resource] // HPSC. – Mode of access: http://www.hpsc.ie/hpsc/A-Z/VaccinePreventable/TuberculosisTB/Publications/-ConsultationDocuments/File.2991.en.pdf
  53. Dridi A., Kaaroud H., Boubaker K. et al. Tuberculosis in renal transplant recipients // Transplant. Proc. – 2003; 7 (35): 2682–3. DOI: 10.1016/j.transproceed.2003.08.064.
  54. Aguado J., Torre-Cisneros J., Fortún J. et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology // Clin. Infect. Dis. – 2009; 48 (9): 1276–84. DOI: 10.1086/597590.
  55. Anand M., Nayyar E., Concepcion B. et al. Tuberculosis in kidney transplant recipients: a case series // World J. Transplant. – 2017; 7 (3): 213–21. DOI: 10.5500/wjt.v7.i3.213.
  56. Meije Y., Piersimoni C., Torre-Cisneros J. et al. Mycobacterial infections in solid organ transplant recipients // Clin. Microbiol. Infect. – 2014; 20 (7): 89–101. DOI: 10.1111/1469-0691.12641.
  57. Артюхина Л.Ю., Иванова Е.С., Фролова Н.Ф. и др. Особенности течения туберкулезной инфекции на фоне иммуносупрессии у реципиентов почки // Лечебное дело. – 2015; 1: 11–7 [Artyukhina L.Yu., Ivanova E.S., Frolova N.F. et al. Tuberculosis in Kidney Transplant Recipients // Lechebnoe delo. – 2015; 1: 11–7 (in Russ.)].
  58. Sundaram M., Adhikary S., John G. et al. Tuberculosis in renal transplant recipients // Indian J. Urol. – 2008; 24 (3): 396–400. DOI: 10.4103/0970-1591.42625.
  59. Клинические рекомендации «Диагностика, лечение и профилактика инфекционных осложнений у пациентов с трансплантированной почкой» / М.: Научное общество нефрологов России, Ассоциация нефрологов России, 2014 [Klinicheskie rekomendatsii «Diagnostika, lechenie i profilaktika infektsionnykh oslozhnenii u patsientov s transplantirovannoi pochkoi» / M.: Nauchnoe obshchestvo nefrologov Rossii, Assotsiatsiya nefrologov Rossii, 2014 (in Russ.)].